Desmond-Hellmann discusses the drug development process and shares her experience with the targeted cancer therapeutic, Herceptin.
|Download:||This Video Subtitled Videos: English|
|Trouble Viewing? Try it on iTunes.Report a problem.|
About the Speaker
An oncologist and leader in biotechnology, Susan Desmond-Hellmann is currently Chancellor of the University of California San Francisco. Prior to joining UCSF, Desmond-Hellmann spent 14 years at Genentech where she served as President, Product Development from 2004-2009. Under her direction, Genentech became the nation’s No. 1 producer of anti-cancer drug treatments.
- Brian Druker iBioSeminar: Imatinib (Gleevec): A Targeted Cancer Therapy
- Mark Tessier-Lavigne iBioMagazine: Careers in Biotechnology
- Wells and Akin iBioSeminar: Introduction to Drug Discovery